Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. [electronic resource]
Producer: 20080129Description: 83-9 p. digitalISSN:- 1527-7755
- Adenocarcinoma, Clear Cell -- drug therapy
- Adenocarcinoma, Mucinous -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Endometrioid -- drug therapy
- Cisplatin -- administration & dosage
- Cystadenocarcinoma, Serous -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Medical Records
- Middle Aged
- Neoplasm Staging
- Neoplasm, Residual -- etiology
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Pleural Effusion, Malignant -- etiology
- Postoperative Complications -- etiology
- Prognosis
- Randomized Controlled Trials as Topic
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.